Form 4 Filing: SCHMITT DANIEL M Buys $50K of $ACTU

INSIDER PURCHASE

⚡ MATERIALITY: 7/10

corporate issuer

ACTUATE THERAPEUTICS, INC.

Ticker: $ACTU

Transaction Value

$50K

Price/Share: $0.35

transaction date

2026-10-28

Shares: 140,844

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, SCHMITT DANIEL M, holds the title of President, CEO and Director at ACTUATE THERAPEUTICS, INC..

On 2026-10-28, the insider transacted 140,844 shares.The shares were transacted at a weighted average price of $0.35 per share, resulting in a total market-relevant value of $50K.

Executive Summary Summary

SCHMITT DANIEL M (President, CEO and Director) bought $50K of $ACTU

Post-Transaction Position: 442,560 shares

SEC Accession No: 0001683168-26-008147 (CIK: 1318470)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$ACTU Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$ACTU News Coverage